Business Wire

Winterproof Your Bike With Moto-tyres.co.uk

Del

The days are getting colder, and dead leaves are dancing over the asphalt – an unmistakable sign that the biking season is drawing to a close.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171107006065/en/

Get your bike ready for next year now with the right maintenance and new tyres (Photo: Business Wire ...

Get your bike ready for next year now with the right maintenance and new tyres (Photo: Business Wire)

“Keen bikers aren’t going to be put off by cooler weather alone. It’s often still sunny in autumn, and bikers will still feel the urge to hit the road. So don’t put your bike away too soon, or you’ll miss these beautiful moments”, says Oliver Pflaum of Moto-tyres.co.uk.

Cold and snow will soon rule the roads, however, meaning that many bikers are ready to winterproof their bikes. Simply sticking your bike in the garage or covering it with a breathable tarp isn’t enough. But with a bit of care and attention, you can make sure that even the most rust-prone parts of your bike survive the winter unscathed. First of all, take your bike to a car wash and clean it with an oil separator, as old oil can corrode the engine. Even if a full oil change isn’t required, check the oil level and top up if necessary. Find the perfect products in the extensive range available at Moto-tyres.co.uk.

Many bikers ask if their bike should spend the winter with a full or empty tank. It depends: if your bike has a steel tank, you should fill it completely to prevent condensation from building up and corroding the tank. But if you have a plastic tank, you should empty it to prevent diffusion. If you want to be on the safe side, you should do the same with the carburetor, unless your bike has electric fuel injection, of course, and therefore no carburetor. You should also check the antifreeze levels, and change/refill if necessary. Remove the battery for the winter and store it somewhere cool and dry, charging occasionally. Increase the tyre pressure by 0.3 bar, and mount your bike on an assembly stand or a block of wood, so that the bike’s tyres aren’t touching the ground and are therefore not under pressure. If the pressure in the tyres is relieved, the casing won’t warp. When it comes to the tyres: you should take a good look at the tyre tread. If you see any damage or the tyres are worn, deal with this immediately. Great value tyres are available at Moto-tyres.co.uk. If you are buying off-season tyres you can often make even greater savings. Finding the right tyres is made even easier thanks to the bike model search field.

As a rule, tyres and tubes are immediately available, and delivery is free from the very first tyre. Another bonus: Moto-tyres.co.uk offers customers the option to have their tyres delivered to one of countless fitting partners at no extra cost, where their new tyres will be expertly fitted and their old tyres disposed of. Simply choose a fitting partner during the ordering process. For more information and to find a fitting partner near you, go to: https://www.moto-tyres.co.uk/cgi-bin/stationssuche.pl.

About Moto-tyres.co.uk

Whether you're looking for chopper, sport-touring or scooter tyres: bikers will find everything their heart desires in this renowned online store's range. Accessories such as bike tubes and motor oil complete Delticom's bike range. The two-wheeler tyre specialist's portfolio includes all established premium bike tyre manufacturers such as Metzeler, Pirelli, Continental, Dunlop, Bridgestone and Michelin, as well as renowned quality brands such as Heidenau, Avon, Maxxis and Mitas.

Online store for end users: www.moto-tyres.co.uk

Further online stores in Europe: www.MotorradreifenDirekt.de (DE), www.MotorradreifenDirekt.at (AT), www.MotorradreifenDirekt.ch (CH), www.pneus-moto.fr (FR), www.motorbandenmarkt.nl (NL), www.moto-pneumatici.it (IT), www.neumaticosdemoto.es (ES) and more.

Online store for dealers: www.yourtyres.co.uk

About the company: www.delti.com

Contact information

Press contact:
insignis Agentur für
Kommunikation GmbH (GPRA)
Henning Jahns
Tel.: +49-511-132214-14
Fax: +49-511-132214-99
delticom@insignis.de
or
Delticom AG
Anne Lena Peters
Tel.: +49-511-93634-8909
Fax: +49-511-93634-8301
anne.lena.peters@delti.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Outline of New ESMO Guidelines Indicates Inclusion of FOTIVDA®▼ (Tivozanib) for Patients with Advanced Renal Cell Carcinoma22.10.2018 07:51Pressemelding

EUSA Pharma (EUSA) welcomes the news that FOTIVDA®▼ (tivozanib) is expected to be included in the upcoming European Society of Medical Oncology (ESMO) clinical practice guidelines for advanced renal cell carcinoma (aRCC), anticipated to be published at the end of this year.1 The outline of the new proposed guidelines was presented on 19th October at the annual ESMO 2018 Congress in Munich, Germany, and indicated that tivozanib will be included as a first-line treatment recommendation for aRCC clear cell histology patients. The update will position tivozanib as a treatment standard for good (or favourable) risk patients with a Class IIa recommendation, and a treatment option for intermediate risk patients with a Class IIb recommendation.1 The indication of inclusion of tivozanib in the ESMO guidelines follows the grant of a European Commission (EC) licence in August 2017 for this oral, once-daily,a potent selective vascular endothelial growth factor receptor tyrosine kinase inhibitors (

Open Fiber Powers Its Optical Network With SM Optics WDM ROADM22.10.2018 07:00Pressemelding

Open Fiber a national wholesales operator awards SM Optics, part of SIAE MICROELETTRONICA group a contract to supply and deploy WSS-free WDM ROADM technology extending fibre connectivity from their fibre backbone to metro/regional sites. The new network transports the FTTH (fibre-to-the-home) and FWA (Fixed-wireless-access) aggregated traffic, delivering ultra-broadband service to houses and local businesses. Open Fiber mission is to build a nationwide fiber network, bringing fibre connectivity to the vast majority of households and enterprises in the country, with a target of almost 19 million property units. This optical access infrastructure will enable operators delivering next generation services from FTTH broadband network for data, gaming, video streaming and mobile connectivity to 5G and IoT. SM Optics optical transport solution offers unprecedented flexibility in the smallest footprint, successfully meeting the challenge of limited space deployment and low power consumption. F

Zscaler Extends Cloud DLP Service with Inline Exact Data Match for Massive Data Sets Covering Users Globally22.10.2018 06:30Pressemelding

Zenith Live Europe – Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced inline Exact Data Match (EDM) with native SSL inspection as part of its advanced Cloud Data Loss Prevention (DLP) service. The inline EDM capability extends the Zscaler™ cloud platform to protect against the loss of sensitive information across all users and branches with more precision while reducing the number of false positives to near zero. This service is provided in the Zscaler cloud, providing the capacity of one billion data points per customer across 100 data centers globally. Traditional DLP appliances that sit in the data center are expensive and resource-intensive, and their protection can be subpar, often failing to alert an organization until after data has been compromised. Zscaler’s inline EDM with native SSL inspection blocks sensitive information before it leaves the network. In the first half of 2018, the Zscaler cloud platform blocked an average of 800,000 SSL-encrypted tr

Vivior Chairman Receives Award for Outstanding Contributions to Refractive Surgery22.10.2018 06:00Pressemelding

Michael Mrochen, PhD, Chairman of the Board of Directors at Vivior, receives the Casebeer Award from the International Society of Refractive Surgery. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181021005012/en/ Michael Mrochen, PhD Chairman of the Board of Directors Vivior AG (Photo: Business Wire) The International Society of Refractive Surgery (ISRS), a partner of the American Academy of Ophthalmology, is the leading worldwide organization for refractive surgeons. Each year, ISRS awards members for their special contributions to the ISRS, as well as their dedication to the field. The Casebeer Award recognizes an individual for his or her outstanding contributions to refractive surgery through nontraditional research and development activities (https://www.isrs.org/about-isrs/awards). Michael Mrochen is internationally known for his pioneering work on corneal laser surgery, corneal cross linking, ocular biometry and corn

Investigational Subcutaneous Formulation of Vedolizumab Achieves and Maintains Clinical Remission and Mucosal Healing at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis22.10.2018 05:00Pressemelding

Takeda Pharmaceutical Company Limited [TSE:4502] (“Takeda”) today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous (SC) formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis (UC) who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous (IV) induction therapy. At week 52, a statistically significant proportion of patients receiving vedolizumab SC achieved clinical remission** compared to patients receiving placebo (46.2% vs. 14.3%; p<0.001). A similar rate of clinical remission was observed in the vedolizumab IV reference arm (42.6%). These results were presented at the 2018 United European Gastroenterology (UEG) Week congress in Vienna, Austria. “The VISIBLE 1 results highlight that the investigational subcutaneous formulation of vedolizumab helped patients with moderat

Incyte Announces Positive Interim Data from Phase 2 Trial of Pemigatinib, Its Selective FGFR Inhibitor, in Patients with Cholangiocarcinoma21.10.2018 10:45Pressemelding

Incyte Corporation (Nasdaq:INCY) announces updated data from its ongoing Phase 2 FIGHT-202 trial evaluating pemigatinib (INCB54828), its selective fibroblast growth factor receptor (FGFR) inhibitor, in patients with advanced/metastatic or surgically unresectable cholangiocarcinoma (bile duct cancer) who failed at least one previous treatment. In patients with FGFR2 translocations who were followed for at least eight months, interim study results demonstrated an overall response rate (ORR) of 40 percent, the primary endpoint, and a median progression free survival (PFS) of 9.2 months, a key secondary endpoint. These results are being presented at the European Society for Medical Oncology (ESMO) 2018 Congress in Munich, Germany in a poster presentation on Sunday, October 21 from 12:45 p.m. CEST to 1:45 p.m. CEST (6:45 a.m. ET to 7:45 a.m. ET). (Location: Hall A3 – Poster Area Networking Hub; Abstract #756P) “We are pleased to share updated interim results from our ongoing FIGHT-202 trial